Stay updated with breaking news from Agenus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Agenus Inc. (NASDAQ:AGEN – Get Rating) were up 5.1% on Wednesday . The stock traded as high as $1.55 and last traded at $1.54. Approximately 2,814,240 shares were traded during trading, a decline of 41% from the average daily volume of 4,753,185 shares. The stock had previously closed at $1.46. Wall Street Analysts […]
Agenus Inc. (NASDAQ:AGEN – Get Rating)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $1.41, but opened at $1.45. Agenus shares last traded at $1.44, with a volume of 1,865,562 shares trading hands. Analysts Set New Price Targets Several research firms have recently weighed in on AGEN. […]
StockNews.com began coverage on shares of Agenus (NASDAQ:AGEN – Get Rating) in a research report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other analysts have also commented on AGEN. HC Wainwright reissued a buy rating and issued a $8.00 target price on shares of Agenus […]
Genus plc (LON:GNS – Get Rating) insider Iain Ferguson acquired 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 16th. The stock was bought at an average cost of GBX 2,479 ($31.05) per share, for a total transaction of £24,790 ($31,053.49). Genus Price Performance Shares of GNS opened at GBX […]
Genus plc (LON:GNS – Get Rating) insider Iain Ferguson bought 1,000 shares of the firm’s stock in a transaction dated Tuesday, May 16th. The shares were acquired at an average price of GBX 2,479 ($31.05) per share, for a total transaction of £24,790 ($31,053.49). Genus Stock Down 2.4 % LON GNS opened at GBX 2,484 […]